Beam Therapeutics Inc. Quarterly Debt-to-equity in % from Q3 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Beam Therapeutics Inc. quarterly Debt-to-equity history and growth rate from Q3 2020 to Q3 2024.
  • Beam Therapeutics Inc. Debt-to-equity for the quarter ending September 30, 2024 was 48.4 %, a 33.2% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 48.4 -24 -33.2% Sep 30, 2024
Q2 2024 52.3 -25.8 -33% Jun 30, 2024
Q1 2024 56.8 -24.1 -29.8% Mar 31, 2024
Q4 2023 63.1 -17.7 -21.9% Dec 31, 2023
Q3 2023 72.4 -7.31 -9.18% Sep 30, 2023
Q2 2023 78 +11.8 +17.7% Jun 30, 2023
Q1 2023 80.8 +18.1 +28.8% Mar 31, 2023
Q4 2022 80.8 +21.8 +36.8% Dec 31, 2022
Q3 2022 79.7 +25.4 +46.7% Sep 30, 2022
Q2 2022 66.3 +2.75 +4.33% Jun 30, 2022
Q1 2022 62.8 +5.95 +10.5% Mar 31, 2022
Q4 2021 59.1 +14.8 +33.5% Dec 31, 2021
Q3 2021 54.3 +0.6 +1.12% Sep 30, 2021
Q2 2021 63.5 Jun 30, 2021
Q1 2021 56.8 Mar 31, 2021
Q4 2020 44.2 Dec 31, 2020
Q3 2020 53.7 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.